Specialties
Peptide hormones.
Short protein signals that move biology with precision. Prescribed where the data and the case call for them.
Why it matters
Peptides are the body's own signaling molecules — short chains of amino acids that orchestrate growth, repair, immune function, hormone release, and tissue recovery. Therapeutic peptides have evolved from a fringe topic into a real clinical tool. The space is also crowded with overpromised claims and unregulated sources, which is exactly why a board-certified physician trained in peptide hormones matters.
What it is
Bio-identical signaling molecules used to modulate specific biological pathways. GLP-1 agonists for metabolic and cardiovascular benefit. Growth hormone secretagogues (sermorelin, CJC-1295, ipamorelin) for sleep, recovery, and aging biology. BPC-157 and TB-500 for tissue repair. Thymosin variants for immune modulation. Each targets a specific receptor or pathway. Each is a tool, not a lifestyle.
What I read for
The clinical question that calls for a peptide, not the peptide as a default. Is a hormone already out of range and worth replacing directly? Is there a specific tissue concern — tendon, joint, gut barrier — where a peptide is the right fit? Is metabolic health the priority? Is this about recovery, aging biology, or a targeted indication? The peptide is the answer, not the question.
Signs it isn't working
What this shows up as.
Most cases touch more than one of these. Recognize what you feel.
- Slow recovery from injury, surgery, or hard training.
- Poor sleep architecture despite addressing the obvious inputs.
- Growth hormone decline showing up clinically with labs to match.
- Sub-clinical thyroid or adrenal patterns that do not quite warrant full replacement.
- Targeted metabolic concerns where GLP-1 is the right fit on top of the basics.
- Athletic recovery and aging biology, with everything else already in place.
Levers
Things you can do.
Practical, ordered roughly by impact. The plan that fits you depends on what your biology shows.
01
Sleep first, always
Most age-related growth hormone decline is reversible with sleep and circadian discipline. Peptides do not replace a broken foundation.
02
Strength train
Heavy lifting produces a substantial endogenous growth hormone pulse. Earn the baseline before adding signaling on top.
03
Insulin sensitivity first
GLP-1 use without addressing the underlying metabolic system loses most of its long-term value when the medication stops.
04
Address hormones, gut, and stress before peptides
Most of what people want from peptides is actually downstream of the basics. Do those first. Then peptides are a force multiplier.
05
Use peptides as protocols, not lifestyles
Cycles, with measurement before and after, and a defined exit. Continuous use without monitoring is how the field gets a bad name.
Work with me
This area inside the Partnership.
The panels that read this system run as part of a Precision Partnership membership. I interpret your data into a written Plan that traces every recommendation back to a finding.
Connected systems
Read alongside.
No system stands alone. These are the areas that interact most with this one.
Questions
About Peptide hormones.
Are peptides FDA approved?
Some are. GLP-1 agonists, certain growth hormone secretagogues, and others have FDA approval. Many therapeutic peptides are compounded under physician prescription through licensed compounding pharmacies. I work only within those legal channels.
Where do GLP-1 medications fit in your practice?
GLP-1s (semaglutide, tirzepatide) are real medications with real benefit when the data supports them. I prescribe them as part of a Plan, with monitoring and an explicit exit strategy. They are not a forever drug for most patients.
Is this for performance or aesthetics?
Mostly no. The framework is health restoration first. I will not prescribe peptides outside of a clinical indication, and I will not chase aesthetic targets that are not also health-positive.
How are peptides obtained?
Through licensed compounding pharmacies on a physician prescription. Not gray-market sources. The quality control of the compounding pharmacy is most of the safety story.
Are they safe?
Within evidence-based dosing and protocols, yes. Outside those protocols, the risk profile grows quickly. Most of the trouble in this field comes from self-administered, unregulated peptides at doses no physician would prescribe.
Will you prescribe peptides on a first visit?
Almost never. The diagnostic work and the foundational levers come first. Peptides are introduced when the case is clear and the rest of the system is set up to use them.